10 results on '"Khairallah, Moncef"'
Search Results
2. A Review of Human Ocular RNA Virus Infections Excluding Coronavirus, Human T-Cell Lymphotropic Virus, and Arboviruses.
- Author
-
Smit, Derrick P., Mathew, Dony K., Khairallah, Moncef, Yeh, Steven, and Cunningham Jr, Emmett T.
- Subjects
- *
RNA virus infections , *HTLV , *CORONAVIRUS diseases , *IRIDOCYCLITIS , *RESPIRATORY syncytial virus infections , *ARBOVIRUSES , *EYE inflammation - Abstract
We provide an updated review of pre-selected RNA viruses causing ocular inflammation in humans. RNA viruses such as coronaviruses and arboviruses are reviewed elsewhere. A Google Scholar search was conducted to identify recent publications on ocular inflammation caused by the RNA viruses specified here. Human RNA viruses target a wide range of ocular tissues from the anterior to the posterior. Influenza, measles and mumps cause anterior segment manifestations including conjunctivitis and keratitis, while retinitis and optic neuritis may be seen posteriorly. Newcastle disease and RSV cause conjunctivitis, whereas HIV causes characteristic anterior uveitis. Cataracts, microphthalmos, and iris abnormalities are common in congenital Rubella, while Rubella virus is associated with Fuchs uveitis syndrome. Newer technologies make it possible to detect more than one pathogen if present simultaneously. RNA viruses may produce significant ocular morbidity, and care should be taken to investigate ocular symptoms during disease outbreaks. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Emergent Infectious Uveitis.
- Author
-
Khairallah, Moncef, Jelliti, Bechir, and Jenzeri, Salah
- Subjects
- *
UVEITIS , *EYE inflammation , *UVEAL diseases , *COMMUNICABLE diseases , *DIAGNOSIS , *HERPESVIRUS diseases , *TOXOPLASMOSIS , *TUBERCULOSIS , *CHIKUNGUNYA - Abstract
Infectious causes should always be considered in all patients with uveitis and it should be ruled out first. The differential diagnosis includes multiple well-known diseases including herpes, syphilis, toxoplasmosis, tuberculosis, bartonellosis, Lyme disease, and others. However, clinicians should be aware of emerging infectious agents as potential causes of systemic illness and also intraocular inflammation. Air travel, immigration, and globalization of business have overturned traditional pattern of geographic distribution of infectious diseases, and therefore one should work locally but think globally, though it is not possible always. This review recapitulates the systemic and ocular mainfestations of several emergent infectious diseases relevant to the ophthalmologist including Rickettsioses, West Nile virus infection, Rift valley fever, dengue fever, and chikungunya. Retinitis, chorioretinitis, retinal vasculitis, and optic nerve involvement have been associated with these emergent infectious diseases. The diagnosis of any of these infections is usually based on pattern of uveitis, systemic symptoms and signs, and specific epidemiological data and confirmed by detection of specific antibody in serum. A systematic ocular examination, showing fairly typical fundus findings, may help in establishing an early clinical diagnosis, which allows prompt, appropriate management. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
4. Pattern of Childhood-Onset Uveitis in a Referral Center in Tunisia, North Africa.
- Author
-
Khairallah, Moncef, Attia, Sonia, Zaouali, Sonia, Yahia, Salim Ben, Kahloun, Rim, Messaoud, Riadh, Zouid, Sonia, and Jenzeri, Salah
- Subjects
- *
PEDIATRIC diagnosis , *UVEITIS , *EYE examination , *EYE inflammation , *EYE diseases - Abstract
Purpose : To analyze the pattern of childhood uveitis in a referral center in Tunisia, North Africa. Methods :The study included 64 patients with uveitis examined at the Department of Ophthalmology of Monastir (Tunisia) from January 1994 to July 2005. All patients had a comprehensive ocular and systemic history, including an extensive review of medical systems. Complete ophthalmic examination was performed in all cases, including best-corrected Snellen visual acuity, slit-lamp examination, applanation tonometry, and dilated fundus examination with 3-mirror lens. Standard diagnostic criteria were employed for all syndromes or entities of uveitis. Results : The mean age at onset of uveitis was 12.4 years. The male-to-female ratio was 0.68. The process was unilateral in 51.6% of patients. Mean follow-up was 43.2 months. Anterior and intermediate uveitis each represented 31.25% of cases, posterior uveitis 20.3%, and panuveitis 17.2%. Noninfectious uveitis (75%) was the most frequent type of inflammation. Idiopathic uveitis was found in 50% of patients. Infectious uveitis was responsible for 25% of the cases, with toxoplasmosis (14.1%) being the most frequent cause. Twenty percent of the patients had systemic associations; juvenile idiopathic arthritis was found in 6.25%. Ocular complications occurred in 74.7% of affected eyes, of which the most common were posterior synechiae (28.4%), cataract (17.9%), cystoid macular edema (19%), and optic disc edema (32.6%). Fifty-seven affected eyes (60%) had a final visual acuity more than 20/40 and nine (9.5%) had a final visual acuity less than 20/200. Conclusions : In a hospital population in Tunisia, a specific cause of uveitis in children was found in half the patients. Idiopathic intermediate uveitis was the leading cause of uveitis in our study, followed by idiopathic anterior uveitis and toxoplasmosis. Uveitis associated with juvenile idiopathic arthritis was rare. Visual prognosis appeared to be good. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
5. Behçet Uveitis.
- Author
-
Cunningham, Emmett T., Tugal-Tutkun, Ilknur, Khairallah, Moncef, Okada, Annabelle A., Bodaghi, Bahram, and Zierhut, Manfred
- Subjects
- *
BEHCET'S disease , *UVEITIS , *EYE inflammation , *UVEAL diseases , *RETINAL diseases - Abstract
The author reflects on Behcet Uveitis (BU). Topics discussed include Behcet disease (BD) as a systemic disorder; and ocular complications of BU that are edema, non-perfusion, neovascularization, and atrophy of the retina and optic disc. Also being discussed are tumor necrosis factor (TNF) inhibitor or interferon, conventional immunosuppressive therapy, and indocyanine green angiography (ICGA) and fundus autofluroescence (FAF).
- Published
- 2017
- Full Text
- View/download PDF
6. Interobserver Agreement in Scoring of Dual Fluorescein and ICG Inflammatory Angiographic Signs for the Grading of Posterior Segment Inflammation.
- Author
-
Tugal-Tutkun, Ilknur, Herbort, Carl P., Khairallah, Moncef, and Mantovani, Alessandro
- Subjects
- *
FLUORESCEIN , *UVEITIS , *EYE inflammation , *MEDICAL radiography , *PHTHALEINS - Abstract
Purpose: To test interobserver agreement in the fluorescein/indocyanine green angiography (FA/ICGA) scoring system for uveitis. Methods: Four observers scored 32 dual FA/ICGAs. Spearman rank correlation was used to analyze correlation between pairs of observers in scores assigned to angiographic signs. Kappa statistics were used to test agreement between pairs of observers in comparative total FA and ICGA scores. Results: The authors found a significant correlation between pairs of observers in scores assigned to all FA signs and all except one ICGA sign. The only discordant sign was early stromal vessel hyperfluoresence on ICGA. There was a moderate to substantial agreement between pairs of observers in comparative FA/ICGA total scores. Conclusions: The level of agreement between uveitis specialists in scoring of dual FA/ICGA indicates that the scoring system tested in this study will be useful for clinical studies of uveitis. Increased experience with this system may further improve its reproducibility. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
7. 3-day treatment with azithromycin 1 .5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.
- Author
-
Cochereau, Isabelle, Meddeb-Ouertani, Amel, Khairallah, Moncef, Amraoui, Abdelouahed, Zaghioul, Khalud, Pop, Mihai, Delval, Laurent, Pouliquen, Pascale, Tandon, Radhika, Garg, Prashant, Goldschmidt, Pablo, and Bourcier, Tristan
- Subjects
- *
CONJUNCTIVITIS treatment , *EYE inflammation , *AZITHROMYCIN , *TOBRAMYCIN , *ANTIBACTERIAL agents , *MACROLIDE antibiotics , *THERAPEUTICS - Abstract
Aim: To compare the efficacy and safety of Azyter, azithromycin 1.5% eye drops, for 3 days with tobramycin 0.3% for 7 days to treat purulent bacterial conjunctivitis. Methods: This was a multicentre, randomised, investigator-masked study including 1043 children and adults with purulent bacterial conjunctivitis. Patients received either azithromycin 1.5% twice-daily for 3 days or tobramycin 0.3%, 1 drop every two hours for 2 days, then four times daily for 5 days. Clinical signs were evaluated and cultures obtained at DO, D3 and D9 (where D refers to "day"). Primary variable was the clinical cure at the Test-of-Cure (TOC)-visit (D9± 1), for patients with DO-positive cultures. The cure was defined as: bulbar conjunctival injection and discharge scores of 0. Results: Among 471 patients with DO-positivity in the per protocol set, 87.8% of the azithromycin 1 .5% group and 89.4% of the tobramycin group were clinically cured at the TOC-visit. Azithromycin was non-inferior to tobramycin for clinical and bacteriological cure. Clinical cure was significantly higher with azithromycin 1.5% at D3. The safety profile of azithromycin was satisfactory with a good patient and investigator's acceptability. Conclusions: Azithromycin 1.5% For 3 days was as effective and as safe as tobramycin for 7 days. Furthermore, more azithromycin than tobramycin patients presented an early clinical cure at Day 3. Due to its twice daily dosing regimen for 3 days, azithromycin represents a step forward in the management of purulent bacterial conjunctivitis, especially in children. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
8. Hypopyon: Is-it Infective or Noninfective?
- Author
-
Ksiaa, Imen, Abroug, Nesrine, Mahmoud, Anis, Ben Amor, Hager, Attia, Sonia, Khochtali, Sana, and Khairallah, Moncef
- Subjects
- *
EYE inflammation , *LEUCOCYTES , *SYMPTOMS , *BLOOD sedimentation , *DIFFERENTIAL diagnosis - Abstract
Hypopyon usually corresponds to the sedimentation of white blood cells, and it signifies severe intraocular inflammation. This key clinical sign may occur in association with a wide variety of infectious, inflammatory, and neoplastic conditions that may be sight- and, occasionally, life-threatening. A careful history and thorough clinical examination are the cornerstones for orienting the differential diagnosis, identifying the causative agent, and initiating prompt and appropriate treatment. This review outlines the clinical characteristics and management of hypopyon in relation with the underlying causative infectious or noninfectious ocular or systemic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.
- Author
-
Tugal-Tutkun MD, Ilknur, Kadayifcilar MD, Sibel, Khairallah MD, Moncef, Lee, Sung Chul, Ozdal, Pinar, Özyazgan, Yilmaz, Song MD, Ji Hun, Yu, Hyeong Gon, Lehner, Valerie, de Cordoue MD, Agnès, Bernard MD, Oana, Gül MD, Ahmet, Tugal-Tutkun, Ilknur Md, Kadayifcilar, Sibel Md, Khairallah, Moncef Md, Lee, Sung Chul Md PhD, Song, Ji Hun Md, Yu, Hyeong Gon Md PhD, Lehner, Valerie PhD, and de Cordoue, Agnès Md
- Subjects
- *
DISEASE exacerbation , *UVEITIS , *EYE inflammation , *UVEAL diseases , *ADRENOCORTICAL hormones , *THERAPEUTIC use of monoclonal antibodies , *SUBCUTANEOUS injections , *BEHCET'S disease , *CLINICAL trials , *COMPARATIVE studies , *GLUCOCORTICOIDS , *IMMUNOSUPPRESSIVE agents , *INTRAVENOUS injections , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *MONOCLONAL antibodies , *RESEARCH , *VISUAL acuity , *EVALUATION research , *RANDOMIZED controlled trials , *TREATMENT effectiveness - Abstract
Purpose: To evaluate the safety and efficacy of gevokizumab for the treatment of Behçet's disease uveitis in a prospective, open-label, randomized phase 2 trial.Methods: Behçet's disease patients with new acute ocular exacerbation or at risk of exacerbation received 30 or 60 mg gevokizumab every 4 weeks intravenously or subcutaneously, on top of a stable regimen of immunosuppressives and corticosteroids (≤20 mg/day equivalent prednisolone). Patients withdrew in cases of ocular exacerbation.Results: A total of 21 patients were included (17 acute and 4 at-risk; mean duration of uveitis 45.6 ± 37.4 months). There were no serious adverse events related to gevokizumab. Recorded adverse events were mostly associated with exacerbation of uveitis or its complications. Response was evaluated for 14 acute patients and all showed rapid control of acute ocular exacerbation, mostly within 1 week, without any increase in corticosteroid dosage.Conclusions: Gevokizumab was well tolerated and rapidly controlled acute ocular exacerbations of Behçet's disease uveitis without the need for high-dose corticosteroid. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
10. Response to Ilhan and Yolcu's Letter Regarding "Pattern of acute retinal necrosis in a referral center in Tunisia, North Africa".
- Author
-
Khochtali, Sana, Abroug, Nesrine, Ben Yahia, Salim, and Khairallah, Moncef
- Subjects
- *
EYE inflammation , *VARICELLA-zoster virus , *POLYMERASE chain reaction , *MEDICAL referrals , *RETINAL diseases - Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.